Literature DB >> 1708930

Immunogenicity of peptides simulating a neutralization epitope of transmissible gastroenteritis virus.

W P Posthumus1, J A Lenstra, A P van Nieuwstadt, W M Schaaper, B A van der Zeijst, R H Meloen.   

Abstract

Previously, an epitope recognized by a set of neutralizing monoclonal antibodies directed against the S protein of transmissible gastroenteritis has been identified. This neutralization epitope can be simulated by a single peptide combining residues 380 to 387 and 1176 to 1184 of the S protein; this combination peptide (SFFSYGEI-QLAKDKVNE) was more antigenic than it single constituents. Here we describe the immunogenicity of this combination peptide, in comparison with monomer and tandem peptides of both constituents, and with a cyclic peptide consisting of residues 373 to 398. All antisera, raised in rabbits, bound to the peptide used as immunogen. Only sera that recognized the residues 380 to 387 bound to whole virus. Three of the four antisera with the highest binding titers to whole virus also had neutralization activity. Analysis of the fine-specificity of the antisera with PEPSCAN peptides indicated that the spectrum of antibodies induced by the 380 to 387 sequence depended on the presentation of this sequence in a peptide to the immune system. The nonbinding and nonneutralizing anti-(380 to 387)-sera appeared to contain a limited spectrum of antipeptide antibodies. Furthermore, the lack of neutralization of the antiserum against the combination peptide could be explained by the immunodominance in rabbits of the 1176 to 1184 sequence over the 380 to 387 sequence. These findings demonstrate a few fundamental problems of simulating discontinuous epitopes by single synthetic peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708930     DOI: 10.1016/0042-6822(91)90684-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Altering the antigenicity of proteins.

Authors:  H Alexander; S Alexander; E D Getzoff; J A Tainer; H M Geysen; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

Authors:  J P Langeveld; J I Casal; A D Osterhaus; E Cortés; R de Swart; C Vela; K Dalsgaard; W C Puijk; W M Schaaper; R H Meloen
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

3.  Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus.

Authors:  T Tuboly; E Nagy; J R Dennis; J B Derbyshire
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2.

Authors:  Mohamad Hesam Shahrajabian; Wenli Sun; Qi Cheng
Journal:  Hum Vaccin Immunother       Date:  2020-08-12       Impact factor: 3.452

5.  Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.

Authors:  Amruta S Naik; Ania Owsianka; Brendan A Palmer; Ciaran J O'Halloran; Nicole Walsh; Orla Crosbie; Elizabeth Kenny-Walsh; Arvind H Patel; Liam J Fanning
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

6.  A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity.

Authors:  C Smerdou; I M Anton; J Plana; R Curtiss; L Enjuanes
Journal:  Virus Res       Date:  1996-03       Impact factor: 3.303

7.  Isolation of sequences from a random-sequence expression library that mimic viral epitopes.

Authors:  J A Lenstra; J H Erkens; J G Langeveld; W P Posthumus; R H Meloen; F Gebauer; I Correa; L Enjuanes; K K Stanley
Journal:  J Immunol Methods       Date:  1992-08-10       Impact factor: 2.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.